Importantly, prolonged and high level exposure of an OX2R agonist during the sleep phase, which is associated with insomnia, should be avoided, because high-quality sleep is critical to facilitate the removal of pathological proteins from the brain36. Here, HCRTR2 is linked to insomnia.